This topic contains a solution. Click here to go to the answer

Author Question: According to the organismic perspective on personality, a. sex drive has a primary influence on ... (Read 23 times)

newbem

  • Hero Member
  • *****
  • Posts: 579
According to the organismic perspective on personality,
 
  a. sex drive has a primary influence on personality.
  b. people do not have free will.
  c. every person has the potential to grow into a person of value.
  d. environment is less important than biology.

Question 2

High need for power is associated with a
 
  a. lesser tendency to make concessions in negotiation, leading to better outcomes.
  b. lesser tendency to make concessions in negotiation, leading to worse outcomes.
  c. greater tendency to make concessions in negotiation, leading to better outcomes.
  d. greater tendency to make concessions in negotiation, leading to worse outcomes.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

quynhmickitran

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

C

Answer to Question 2

A




newbem

  • Member
  • Posts: 579
Reply 2 on: Jun 21, 2018
Great answer, keep it coming :)


kusterl

  • Member
  • Posts: 315
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library